CY1110975T1 - Κρυσταλλος ενωσεως ινδολης περιεχουσης σουλφοναμιδιο και μεθοδος παραγωγης του - Google Patents
Κρυσταλλος ενωσεως ινδολης περιεχουσης σουλφοναμιδιο και μεθοδος παραγωγης τουInfo
- Publication number
- CY1110975T1 CY1110975T1 CY20101101136T CY101101136T CY1110975T1 CY 1110975 T1 CY1110975 T1 CY 1110975T1 CY 20101101136 T CY20101101136 T CY 20101101136T CY 101101136 T CY101101136 T CY 101101136T CY 1110975 T1 CY1110975 T1 CY 1110975T1
- Authority
- CY
- Cyprus
- Prior art keywords
- crystall
- united
- industry
- production
- sulfonamide
- Prior art date
Links
- 229940124530 sulfonamide Drugs 0.000 title 1
- 150000003456 sulfonamides Chemical class 0.000 title 1
- LWGUASZLXHYWIV-UHFFFAOYSA-N 3-cyano-n-(3-cyano-4-methyl-1h-indol-7-yl)benzenesulfonamide Chemical compound C1=2NC=C(C#N)C=2C(C)=CC=C1NS(=O)(=O)C1=CC=CC(C#N)=C1 LWGUASZLXHYWIV-UHFFFAOYSA-N 0.000 abstract 1
- 238000000634 powder X-ray diffraction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003318953 | 2003-09-10 | ||
| EP04772605A EP1666463B1 (en) | 2003-09-10 | 2004-09-01 | Crystal of sulfonamide-containing indole compound and process for producing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1110975T1 true CY1110975T1 (el) | 2015-06-11 |
Family
ID=34308544
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20101101136T CY1110975T1 (el) | 2003-09-10 | 2010-12-10 | Κρυσταλλος ενωσεως ινδολης περιεχουσης σουλφοναμιδιο και μεθοδος παραγωγης του |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US7754894B2 (https=) |
| EP (1) | EP1666463B1 (https=) |
| JP (1) | JP4435090B2 (https=) |
| KR (1) | KR20060120644A (https=) |
| CN (2) | CN100406440C (https=) |
| AT (1) | ATE486849T1 (https=) |
| AU (1) | AU2004272400B2 (https=) |
| BR (1) | BRPI0414314A (https=) |
| CA (1) | CA2536995C (https=) |
| CY (1) | CY1110975T1 (https=) |
| DE (1) | DE602004029907D1 (https=) |
| DK (1) | DK1666463T3 (https=) |
| ES (1) | ES2354286T3 (https=) |
| HR (1) | HRP20100631T1 (https=) |
| IL (2) | IL174059A0 (https=) |
| MX (1) | MXPA06002732A (https=) |
| NO (1) | NO335256B1 (https=) |
| NZ (1) | NZ546111A (https=) |
| PL (1) | PL1666463T3 (https=) |
| PT (1) | PT1666463E (https=) |
| RU (1) | RU2336269C2 (https=) |
| SI (1) | SI1666463T1 (https=) |
| TW (1) | TW200514770A (https=) |
| WO (1) | WO2005026118A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005026118A1 (ja) * | 2003-09-10 | 2005-03-24 | Eisai Co., Ltd. | スルホンアミド含有インドール化合物の結晶およびその製造方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3868534B2 (ja) * | 1996-05-24 | 2007-01-17 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | スルホンアミド誘導体の製造法および中間体 |
| JP2000247949A (ja) | 1999-02-26 | 2000-09-12 | Eisai Co Ltd | スルホンアミド含有インドール化合物 |
| MXPA02007249A (es) * | 2000-02-03 | 2002-12-09 | Eisai Co Ltd | Inhibidor de la expresion de integrina. |
| TWI283575B (en) * | 2000-10-31 | 2007-07-11 | Eisai Co Ltd | Medicinal compositions for concomitant use as anticancer agent |
| WO2005026118A1 (ja) * | 2003-09-10 | 2005-03-24 | Eisai Co., Ltd. | スルホンアミド含有インドール化合物の結晶およびその製造方法 |
-
2004
- 2004-09-01 WO PCT/JP2004/012649 patent/WO2005026118A1/ja not_active Ceased
- 2004-09-01 EP EP04772605A patent/EP1666463B1/en not_active Expired - Lifetime
- 2004-09-01 CN CNB2004800260696A patent/CN100406440C/zh not_active Expired - Fee Related
- 2004-09-01 DE DE602004029907T patent/DE602004029907D1/de not_active Expired - Lifetime
- 2004-09-01 DK DK04772605.4T patent/DK1666463T3/da active
- 2004-09-01 JP JP2005513843A patent/JP4435090B2/ja not_active Expired - Fee Related
- 2004-09-01 AT AT04772605T patent/ATE486849T1/de active
- 2004-09-01 PL PL04772605T patent/PL1666463T3/pl unknown
- 2004-09-01 CA CA2536995A patent/CA2536995C/en not_active Expired - Fee Related
- 2004-09-01 BR BRPI0414314-0A patent/BRPI0414314A/pt not_active IP Right Cessation
- 2004-09-01 HR HR20100631T patent/HRP20100631T1/hr unknown
- 2004-09-01 MX MXPA06002732A patent/MXPA06002732A/es active IP Right Grant
- 2004-09-01 NZ NZ546111A patent/NZ546111A/en not_active IP Right Cessation
- 2004-09-01 CN CNA2007101667949A patent/CN101165049A/zh active Pending
- 2004-09-01 RU RU2006111454/04A patent/RU2336269C2/ru not_active IP Right Cessation
- 2004-09-01 US US10/571,279 patent/US7754894B2/en not_active Expired - Lifetime
- 2004-09-01 KR KR1020067004877A patent/KR20060120644A/ko not_active Ceased
- 2004-09-01 SI SI200431578T patent/SI1666463T1/sl unknown
- 2004-09-01 PT PT04772605T patent/PT1666463E/pt unknown
- 2004-09-01 ES ES04772605T patent/ES2354286T3/es not_active Expired - Lifetime
- 2004-09-01 AU AU2004272400A patent/AU2004272400B2/en not_active Ceased
- 2004-09-06 TW TW093126889A patent/TW200514770A/zh not_active IP Right Cessation
-
2006
- 2006-03-02 IL IL174059A patent/IL174059A0/en not_active IP Right Cessation
- 2006-04-05 NO NO20061545A patent/NO335256B1/no not_active IP Right Cessation
-
2009
- 2009-01-18 IL IL196569A patent/IL196569A0/en unknown
- 2009-06-09 US US12/480,959 patent/US20090247768A1/en not_active Abandoned
-
2010
- 2010-12-10 CY CY20101101136T patent/CY1110975T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1106425T1 (el) | Ενωσις βενζυλαμινης και φαρμακευτικη χρησις αυτης | |
| CY2016013I2 (el) | Φαρμακευτικες συνθεσεις που περιλαμβανουν βαλσαρτανη και αναστολεις nep | |
| MY154538A (en) | Imprint lithography templates having alignment marks | |
| PL375021A1 (en) | Substituted (thiazol-2-yl) -amide or sulfonamide as glycokinase activators useful in the treatment of type 2 diabetes | |
| FR2853631B1 (fr) | Materiau d'emballage et procede pour sa production | |
| CY1109068T1 (el) | Υποκατεστημενες πυριδινυλαμινες | |
| DE60217363D1 (de) | 17beta-hydroxysteroid dehydrogenase type 3 inhibitoren zur behandlung von androgen-abhängigen erkrankungen | |
| DE602005027126D1 (de) | Schmales zahnimplantat und zugeordnete teile | |
| PL372996A1 (en) | 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl)-n-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition | |
| CY1115162T1 (el) | Νεα μεθοδος βιομηχανικης συνθεσης του ρανελικου στροντιου και των ενυδρων αλατων του | |
| DE602004019795D1 (de) | Kombination aus n-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-ä1,3,4-oxadiazol-2-ylüphenyl)pyridin-3-sulfonamid und einem biphosphonat | |
| CY1107913T1 (el) | Πολυμορφικες και αλλες κρυσταλλικες μορφες cis-ftc | |
| DE50311467D1 (de) | Vorrichtung zum Herstellen von Klappschachteln | |
| EP1666524A4 (en) | Perfluoroelastomer SEAL MATERIAL | |
| CY1110975T1 (el) | Κρυσταλλος ενωσεως ινδολης περιεχουσης σουλφοναμιδιο και μεθοδος παραγωγης του | |
| CY1108238T1 (el) | Μεθοδος συνθεσης της περινδοπριλης και των φαρμακευτικως αποδεκτων αλατων της | |
| ATE458465T1 (de) | Kosmetische und/oder dermatologische zusammensetzung mit bornitrid | |
| IL159726A0 (en) | Protected 3,5-dihydroxy-2,2-dimethyl-valeronitriles for the synthesis of epothilones and derivatives and method for the production and use thereof | |
| DE60228183D1 (de) | Fotopolymerisierbare Zusammensetzung und Aufzeichnungsmaterial | |
| ATE387100T1 (de) | Calciumsalz enthaltender kaugummi | |
| DE60301490D1 (de) | Röntgenopakes und aseptisches Material zum Abdrucknehmen zur Verwendung in Implantodontika | |
| MXPA04000954A (es) | 3,5-dibidroxi-2,2-dimetil-valeroamidas protegidas para la sintesis de epotilonas y derivados, un procedimiento para su preparacion y el empleo de las mismas. | |
| ATE461174T1 (de) | Neue piperidinderivate und deren verwendung als monoaminneurotransmitter-wiederaufnahmehemmer | |
| ATE387857T1 (de) | Calcium enthaltende süssigkeit | |
| FI20025050A0 (fi) | Kartonkituote ja menetelmä sen valmistamiseksi |